Serotype and antimicrobial profile distribution of invasive pneumococcal isolates in the pre-vaccine introduction era in Pretoria, South Africa, 2005 through 2009

Diagnostic Microbiology and Infectious Disease

Volumn 71, Issue 3, 2011, Pages 309-311

  Silberbauer, Eduard Johan ^a   Ismail, Nazir ^a   von Gottberg, Anne ^b   Hoosen, Anwar A ^a  

^a NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Pneumococcus; Pneumococcus conjugate vaccine; South Africa; Streptococcus pneumoniae; Vaccine

Indexed keywords

CEFOTAXIME; PENICILLIN G; PNEUMOCOCCUS VACCINE;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SEROTYPE; SOUTH AFRICA; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; HIV SEROPOSITIVITY; HUMANS; INFANT; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEROTYPING; SOUTH AFRICA; STREPTOCOCCUS PNEUMONIAE; YOUNG ADULT;

EID: 80053925439     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2011.07.006     Document Type: Article

References (13)

1. Centers for Disease Control and Prevention (CDC) Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease-United States, 1998-2003. MMWR. Morb. Mortal. Wkly. Rep. 2005, 54:893-897.
2. Cutts F.T., Zaman S.M., Enwere G., Jaffar S., Levine O.S., Okoko J.B., Oluwalana C., Vaughan A., Obaro S.K., Leach A., McAdam K.P., Biney E., Saaka M., Onwuchekwa U., Yallop F., Pierce N.F., Greenwood B.M., Adegbola R.A. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 2005, 365:1139-1146. Gambian Pneumococcal Vaccine Trial Group.
3. Department of health National antenatal sentinel HIV and syphilis prevalence in South Africa, 2009 Available at, Last accessed 30 August 2011. http://www.info.gov.za/view/DownloadFileAction?id=109007.
4. Goldblatt D., Southern J., Ashton L., Andrews N., Woodgate S., Burbidge P., Waight P., Miller E. Immunogenicity of a reduced schedule of pneumococcal conjugate vaccine in healthy infants and correlates of protection for serotype 6B in the United Kingdom. Pediatr. Infect. Dis. J. 2010, 29:401-405.
5. Hausdorff W.P., Feikin D.R., Klugman K.P. Epidemiological differences among pneumococcal serotypes. Lancet Infect. Dis. 2005, 5:83-93.
6. Huebner R.E., Wasas A.D., Klugman K.P. Trends in antimicrobial resistance and serotypes distributions of blood and cerebrospinal fluid Isolates of Streptococcus pneumoniae in South Africa. Int. J. Infect. Dis. 2000, 4:214-218.
7. Jones N., Huebner R., Khoosal M., Crewe-Brown H., Klugman K. The impact of HIV on Streptococcus pneumoniae bacteraemia in a South African population. AIDS 1998, 12:2177-2184.
8. Karstaedt A.S., Khoosal M., Crewe-Brown H.H. Pneumococcal bacteremia in adults in Soweto, South Africa, during the course of a decade. Clin. Infect. Dis. 2001, 33:610-614.
9. Karstaedt A.S., Khoosal M., Crewe-Brown H.H. Pneumococcal bacteremia during a decade in children in Soweto, South Africa. Pediatr. Infect. Dis. J. 2000, 19:454-457.
10. Madhi S. Introduction of the pneumococcal conjugate vaccine into South African public immunization programme: dawn of a new era?. South Afr. J. Epidemiol. Infect. 2008, 23:5-9.
11. Messina A.F., Katz-Gaynor K., Barton T., Ahmad N., Ghaffar F., Rasko D., McCracken G.H. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005. Pediatr. Infect. Dis. J. 2007, 26:461-467.
12. Perez-Trallero E., Marimon J.M., Ercibengoa M., Vicente D., Perez-Yarza E.G. Invasive Streptococcus pneumoniae infections in children and older adults in the north of Spain before and after the introduction of the heptavalent pneumococcal conjugate vaccine. Eur. J. Clin. Microbiol. Infect. Dis. 2009, 28:731-738.
13. Zar H.J., Madhi S.A. Pneumococcal conjugate vaccine-a health priority. S. Afr. Med. J. 2008, 98:463-467.